Bio-Rad Laboratories BIO Life Science — Goodwill, Impaired, Accumulated Impairment Loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's life science — goodwill, impaired, accumulated impairment loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's life science — goodwill, impaired, accumulated impairment loss?
- Bio-Rad Laboratories (BIO) reported life science — goodwill, impaired, accumulated impairment loss of $41.8M in Q1 2026.
- How has Bio-Rad Laboratories's life science — goodwill, impaired, accumulated impairment loss changed year-over-year?
- Bio-Rad Laboratories's life science — goodwill, impaired, accumulated impairment loss decreased by 0.0% year-over-year, from $41.8M to $41.8M.
- What is the long-term trend for Bio-Rad Laboratories's life science — goodwill, impaired, accumulated impairment loss?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's life science — goodwill, impaired, accumulated impairment loss has grown at a 0.0% compound annual growth rate (CAGR), from $167.2M to $167.2M.
- What does life science — goodwill, impaired, accumulated impairment loss mean?
- The cumulative amount of impairment losses recognized against the goodwill of the Life Science segment. This reflects historical write-downs taken when the carrying value of the segment's goodwill exceeded its implied fair value.